Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
D-cycloserine for numbing and avoidance in chronic PTSD
IRCT2013121015741N1Phase 3Completed
- Sponsor
- Isfahan University of Medical Sciences
- Start
- Oct 2012
- Modality
- Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, single-arm trial of d-cycloserine in post-traumatic stress disorder (PTSD), sponsored by Isfahan University of Medical Sciences. Started Oct 2012; status: completed.
02
Drugs
d-cycloserine
03
Conditions
post-traumatic stress disorder (PTSD)
Beyond the preview
Go deeper on IRCT2013121015741N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT2013121015741N1.